The FDA Said to Receive Death Reports Over Popular Monster (MNST) Energy Drink
Tweet
Share
E-mail
Get Alerts MNST Hot Sheet
Join SI Premium – FREE
Monster Beverage (Nasdaq: MNST) shares are at session lows following a report in the NY Times that the FDA has said it received several incident reports tying the popular energy drink to possible deaths.
Like drug reports, the incident filings don't directly link Monster and the health problems.
However, the Times said a mother filed a suit against Monster after her 14-year-old daughter passed away due to "a heart arrhythmia after drinking large cans of Monster Energy on two consecutive days." She alleges that Monster failed to warn about the risks of its energy drinks.
No comment has been issued by Monster with respect to the FDA filings. Shares are down 4.6 percent on the session.
Like drug reports, the incident filings don't directly link Monster and the health problems.
However, the Times said a mother filed a suit against Monster after her 14-year-old daughter passed away due to "a heart arrhythmia after drinking large cans of Monster Energy on two consecutive days." She alleges that Monster failed to warn about the risks of its energy drinks.
No comment has been issued by Monster with respect to the FDA filings. Shares are down 4.6 percent on the session.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs reviews US consumer staples sales data for August from NielsenIQ
- Trump admin taps former JPMorgan Chase exec Matt Zames to advise social security agency - CNBC
- Quantum Cyber rejects short-seller's offer to halt reports if lawsuit dropped
Create E-mail Alert Related Categories
Litigation, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
